Literature DB >> 22581159

Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease.

R A Ord1.   

Abstract

INTRODUCTION: The management of the N0 neck in early stage oral cancer remains controversial. The evidence in the literature for elective neck dissection, which is reviewed in this paper, is conflicting. My personal view is that most papers mistakenly assume that the N0 equates to an "early stage" neck whereas a neck with palpable nodes represents disease at a "late" stage. DISCUSSION: I believe that this is the same mindset that prevented us from realizing that depth rather than size was the important prognostic determinant for the primary tumor; because the T stage was based on tumor size. The N stage is also based on size and number of nodes and by these criteria N0 would be the earliest stage. However, although an N0 neck with impalpable intra-nodal disease may be regarded as early impalpable disease an N0 neck with microscopic extra-capsular spread (ECS) would be "late/advanced" impalpable disease. Likewise, a clinically positive neck with intra-nodal disease still represents early disease compared to a clinically positive neck with ECS.
CONCLUSION: The lack of trials and studies stratifying NO and N +ve necks into early and late disease and comparing outcomes between these cohorts may explain the lack of clear-cut evidence regarding the role for elective neck dissection.

Entities:  

Mesh:

Year:  2012        PMID: 22581159     DOI: 10.1007/s10006-012-0325-x

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  50 in total

1.  Prognostic indicators of occult metastases in oral cancer.

Authors:  Mario Russolo; Vittorio Giacomarra; Ledia Papanikolla; Giancarlo Tirelli
Journal:  Laryngoscope       Date:  2002-07       Impact factor: 3.325

2.  Metastasis to the lingual lymph node in carcinoma of the tongue.

Authors:  S Ozeki; H Tashiro; M Okamoto; T Matsushima
Journal:  J Maxillofac Surg       Date:  1985-12

Review 3.  Adjuvant therapy in patients with resected poor-risk head and neck cancer.

Authors:  Jacques Bernier; Jan B Vermorken; Wayne M Koch
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

4.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

5.  Gingival carcinoma: retrospective analysis of 72 patients and indications for elective neck dissection.

Authors:  Joshua Lubek; Michel El-Hakim; Andrew R Salama; Xinggang Liu; Robert A Ord
Journal:  Br J Oral Maxillofac Surg       Date:  2010-05-11       Impact factor: 1.651

Review 6.  Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.

Authors:  Alyson Bessell; Anne-Marie Glenny; Susan Furness; Jan E Clarkson; Richard Oliver; David I Conway; Michaelina Macluskey; Sue Pavitt; Philip Sloan; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

7.  High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus.

Authors:  Luc G T Morris; Snehal G Patel; Jatin P Shah; Ian Ganly
Journal:  Head Neck       Date:  2010-10-14       Impact factor: 3.147

Review 8.  Use of decision analysis in planning a management strategy for the stage N0 neck.

Authors:  M H Weiss; L B Harrison; R S Isaacs
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-07

9.  Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction.

Authors:  Eline J C Nieuwenhuis; C René Leemans; J Alain Kummer; Fedor Denkers; Gordon B Snow; Ruud H Brakenhoff; Alain Kummer
Journal:  Lab Invest       Date:  2003-08       Impact factor: 5.662

10.  Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial.

Authors:  C Vandenbrouck; H Sancho-Garnier; D Chassagne; D Saravane; Y Cachin; C Micheau
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.